OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
Expert Opinion on Emerging Drugs (2016) Vol. 21, Iss. 4, pp. 377-391
Closed Access | Times Cited: 55
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
Expert Opinion on Emerging Drugs (2016) Vol. 21, Iss. 4, pp. 377-391
Closed Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review
Vincenzo Solfrizzi, Carlo Custodero, Madia Lozupone, et al.
Journal of Alzheimer s Disease (2017) Vol. 59, Iss. 3, pp. 815-849
Closed Access | Times Cited: 317
Vincenzo Solfrizzi, Carlo Custodero, Madia Lozupone, et al.
Journal of Alzheimer s Disease (2017) Vol. 59, Iss. 3, pp. 815-849
Closed Access | Times Cited: 317
Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review
Semira Abdi Beshir, Aadith Soorya, Affana Parveen, et al.
International Journal of Alzheimer s Disease (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 82
Semira Abdi Beshir, Aadith Soorya, Affana Parveen, et al.
International Journal of Alzheimer s Disease (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 82
Amyloid-β and Parkinson’s disease
Ee Wei Lim, Dag Aarsland, Dominic ffytche, et al.
Journal of Neurology (2018) Vol. 266, Iss. 11, pp. 2605-2619
Closed Access | Times Cited: 98
Ee Wei Lim, Dag Aarsland, Dominic ffytche, et al.
Journal of Neurology (2018) Vol. 266, Iss. 11, pp. 2605-2619
Closed Access | Times Cited: 98
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
Sonya VanPatten, Yousef Al‐Abed
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 12, pp. 5093-5107
Open Access | Times Cited: 92
Sonya VanPatten, Yousef Al‐Abed
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 12, pp. 5093-5107
Open Access | Times Cited: 92
Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
Adam M. Staffaroni, Peter A. Ljubenkov, John Kornak, et al.
Brain (2018) Vol. 142, Iss. 2, pp. 443-459
Open Access | Times Cited: 88
Adam M. Staffaroni, Peter A. Ljubenkov, John Kornak, et al.
Brain (2018) Vol. 142, Iss. 2, pp. 443-459
Open Access | Times Cited: 88
Effects of Nutrition on Cognitive Function in Adults with or without Cognitive Impairment: A Systematic Review of Randomized Controlled Clinical Trials
Laia Gutiérrez-Tordera, Alexandre Folch, Melina Rojas, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 3728-3728
Open Access | Times Cited: 69
Laia Gutiérrez-Tordera, Alexandre Folch, Melina Rojas, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 3728-3728
Open Access | Times Cited: 69
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, et al.
Expert Opinion on Emerging Drugs (2020) Vol. 25, Iss. 3, pp. 319-335
Closed Access | Times Cited: 66
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, et al.
Expert Opinion on Emerging Drugs (2020) Vol. 25, Iss. 3, pp. 319-335
Closed Access | Times Cited: 66
Are Antibodies Directed Against Amyloid-β (Aβ) Oligomers the Last Call For the Aβ Hypothesis of Alzheimer's Disease?
Francesco Panza, Madia Lozupone, Vittorio Dibello, et al.
Immunotherapy (2018) Vol. 11, Iss. 1, pp. 3-6
Open Access | Times Cited: 58
Francesco Panza, Madia Lozupone, Vittorio Dibello, et al.
Immunotherapy (2018) Vol. 11, Iss. 1, pp. 3-6
Open Access | Times Cited: 58
Improving glycaemic control in type 2 diabetes: S timulate insulin secretion or provide beta‐cell rest?
Daniël H. van Raalte, C. Bruce Verchere
Diabetes Obesity and Metabolism (2017) Vol. 19, Iss. 9, pp. 1205-1213
Closed Access | Times Cited: 57
Daniël H. van Raalte, C. Bruce Verchere
Diabetes Obesity and Metabolism (2017) Vol. 19, Iss. 9, pp. 1205-1213
Closed Access | Times Cited: 57
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
Talita P.C. Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, et al.
European Journal of Medicinal Chemistry (2017) Vol. 139, pp. 773-791
Open Access | Times Cited: 51
Talita P.C. Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, et al.
European Journal of Medicinal Chemistry (2017) Vol. 139, pp. 773-791
Open Access | Times Cited: 51
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Sally Hunter, Carol Brayne
Journal of Negative Results in BioMedicine (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Sally Hunter, Carol Brayne
Journal of Negative Results in BioMedicine (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review
Massimo De Martinis, Lia Ginaldi, Maria Maddalena Sirufo, et al.
Medicina (2020) Vol. 56, Iss. 3, pp. 138-138
Open Access | Times Cited: 45
Massimo De Martinis, Lia Ginaldi, Maria Maddalena Sirufo, et al.
Medicina (2020) Vol. 56, Iss. 3, pp. 138-138
Open Access | Times Cited: 45
Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease
Márcia Martins, Renata Silva, Madalena Pinto, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 242-242
Open Access | Times Cited: 41
Márcia Martins, Renata Silva, Madalena Pinto, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 242-242
Open Access | Times Cited: 41
Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders
Alisa E. Shaw, James R. Bamburg
Pharmacology & Therapeutics (2017) Vol. 175, pp. 17-27
Open Access | Times Cited: 47
Alisa E. Shaw, James R. Bamburg
Pharmacology & Therapeutics (2017) Vol. 175, pp. 17-27
Open Access | Times Cited: 47
Does treating hearing loss prevent or slow the progress of dementia? Hearing is not all in the ears, but who’s listening?
Stephen M. Stahl
CNS Spectrums (2017) Vol. 22, Iss. 3, pp. 247-250
Open Access | Times Cited: 42
Stephen M. Stahl
CNS Spectrums (2017) Vol. 22, Iss. 3, pp. 247-250
Open Access | Times Cited: 42
RAGE Signaling in Skeletal Biology
Lilian I. Plotkin, Alyson L. Essex, Hannah M. Davis
Current Osteoporosis Reports (2019) Vol. 17, Iss. 1, pp. 16-25
Open Access | Times Cited: 42
Lilian I. Plotkin, Alyson L. Essex, Hannah M. Davis
Current Osteoporosis Reports (2019) Vol. 17, Iss. 1, pp. 16-25
Open Access | Times Cited: 42
A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms
Danfang Yu, Huanhuan Yan, Jun Zhou, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Danfang Yu, Huanhuan Yan, Jun Zhou, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 39
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
Francesco Panza, Davide Seripa, Madia Lozupone, et al.
Expert Opinion on Biological Therapy (2017) Vol. 18, Iss. 1, pp. 25-35
Closed Access | Times Cited: 36
Francesco Panza, Davide Seripa, Madia Lozupone, et al.
Expert Opinion on Biological Therapy (2017) Vol. 18, Iss. 1, pp. 25-35
Closed Access | Times Cited: 36
Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease
Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 10, pp. 4199-4212
Closed Access | Times Cited: 34
Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 10, pp. 4199-4212
Closed Access | Times Cited: 34
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review
Vincenzo Solfrizzi, Pasquale Agosti, Madia Lozupone, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 95, pp. 480-498
Closed Access | Times Cited: 33
Vincenzo Solfrizzi, Pasquale Agosti, Madia Lozupone, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 95, pp. 480-498
Closed Access | Times Cited: 33
Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice
Hannah M. Davis, Alyson L. Essex, Sinai Valdez, et al.
Bone (2019) Vol. 124, pp. 89-102
Open Access | Times Cited: 33
Hannah M. Davis, Alyson L. Essex, Sinai Valdez, et al.
Bone (2019) Vol. 124, pp. 89-102
Open Access | Times Cited: 33
Genetic Variants and Oxidative Stress in Alzheimer’s Disease
Marta Kowalska, Katarzyna Wize, Michał Prendecki, et al.
Current Alzheimer Research (2020) Vol. 17, Iss. 3, pp. 208-223
Closed Access | Times Cited: 31
Marta Kowalska, Katarzyna Wize, Michał Prendecki, et al.
Current Alzheimer Research (2020) Vol. 17, Iss. 3, pp. 208-223
Closed Access | Times Cited: 31
New insights in drug development for Alzheimer's disease based on microglia function
Ou Qiao, Haixia Ji, Yi Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111703-111703
Open Access | Times Cited: 24
Ou Qiao, Haixia Ji, Yi Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111703-111703
Open Access | Times Cited: 24
Memory-Enhancing Effects of Mangosteen Pericarp Water Extract through Antioxidative Neuroprotection and Anti-Apoptotic Action
Yeonsoo Oh, Hà Thị Thu, Sun-Young Kim, et al.
Antioxidants (2020) Vol. 10, Iss. 1, pp. 34-34
Open Access | Times Cited: 24
Yeonsoo Oh, Hà Thị Thu, Sun-Young Kim, et al.
Antioxidants (2020) Vol. 10, Iss. 1, pp. 34-34
Open Access | Times Cited: 24
The receptor for advanced glycation end products mediates dysfunction of airway epithelial barrier in a lipopolysaccharides-induced murine acute lung injury model
Jiahui Li, Kai Wang, Bo Huang, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107419-107419
Closed Access | Times Cited: 23
Jiahui Li, Kai Wang, Bo Huang, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107419-107419
Closed Access | Times Cited: 23
